The company says Mythos is too dangerous to release publicly. Cybersecurity experts agree the model's capabilities matter, ...
A Canadian pharmaceutical company, headed by two former executives with the company behind Ozempic, hopes to make a generic version of the weight-loss drug in Edmonton. Data protections on the GLP-1 ...
Kantipuly is a preventive medicine and public health resident at McGill University and visiting scholar at the University of New Mexico. Singer is VK Rajah visiting professor of medical ethics at the ...
To learn more about the CNBC CFO Council, visit cnbccouncils.com/cfo Nearly half of U.S. generic prescriptions originate in India, which relies on the Strait of ...
The last decade also included a small crop of zombie films that felt far outside the norm, like international gems Train to Busan and One Cut of the Dead, the holiday musical Anna and the Apocalypse, ...
I open my emails to find yet another message from a patient about their amphetamine-dextroamphetamine (the generic form of Aderall) no longer working. Dr. Plutchik, my meds no longer seem to be ...
But a ProPublic investigation found that the FDA rarely tests the quality of generic drugs, many of them manufactured overseas. National reporter Debbie Cenziper of ProPublica was one of the authors ...
Please provide your email address to receive an email when new articles are posted on . The sterile, preservative-free formulation is the generic equivalent of Restasis. In patients treated with the ...
A few years ago, a leading U.S. hospital system rolled out a predictive AI model for patient readmissions. It had all the right components: a large training dataset, modern architecture and a ...
Out Of Order is a Java-based interactive game designed to test and improve the player's cognitive abilities. In this game, players are presented with a sequence of characters or numbers that are out ...
Vibe coding — the fast-growing trend of using generative AI to spin up code from plain-language prompts — is quick, creative, and great for instant prototypes. But many argue that it's not cut out for ...
The Food and Drug Administration said it will take steps to speed up the process of developing generic versions of complex biological drugs, in a bid to increase cheaper competition for expensive ...